Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Charles River
Biotech
Cabaletta corrals cell therapy Legend—Chutes & Ladders
Cabaletta corrals cell therapy Legend. Ashvattha eyes growth with ophthalmology vet as interim CEO. Alentis adopts seasoned CEO as leader.
Darren Incorvaia
,
Zoey Becker
Oct 17, 2025 8:30am
Former FDA deputy to guide Charles River animal testing strategy
Oct 15, 2025 10:00am
Charles River launches strategic review, shakes up board
May 7, 2025 11:14am
Chinese CRO expands in US as industry weighs FDA animal shift
Apr 20, 2025 2:50pm
Charles River cuts staff at Tennessee cell therapy site
Feb 19, 2025 2:33pm
CROs should brace for continued slow Big Pharma demand: analyst
Jan 28, 2025 3:45pm
